In adipocytes, activation of GPR81 by L-lactate prevents lipid breakdown and promotes storage of energy-rich metabolites in adipocytes.2,6 Synthetic GPR81 agonists7–9 are potential therapies for dyslipidemia and inhibit lipolysis in cultured adipocytes and in vivo. This evidence concerns the gene HCAR1 and metabolic syndrome.